Evers Nynke M, van den Berg Johannes H J, Wang Si, Melchers Diana, Houtman René, de Haan Laura H J, Ederveen Antwan G H, Groten John P, Rietjens Ivonne M C M
Division of Toxicology, Wageningen University, Tuinlaan 5, 6703 HE Wageningen, the Netherlands.
Division of Toxicology, Wageningen University, Tuinlaan 5, 6703 HE Wageningen, the Netherlands.
J Steroid Biochem Mol Biol. 2014 Sep;143:376-85. doi: 10.1016/j.jsbmb.2014.06.002. Epub 2014 Jun 9.
The aim of the present study was to investigate modulation of the interaction of the ERα and ERβ with coregulators in the ligand responses induced by estrogenic compounds. To this end, selective ERα and ERβ agonists were characterized for intrinsic relative potency reflected by EC50 and maximal efficacy towards ERα and ERβ mediated response in ER selective reporter gene assays, and subsequently tested for induction of cell proliferation in T47D-ERβ cells with variable ERα/ERβ ratio, and finally for ligand dependent modulation of the interaction of ERα and ERβ with coregulators using the MARCoNI assay, with 154 unique nuclear receptor coregulator peptides derived from 66 different coregulators. Results obtained reveal an important influence of the ERα/ERβ ratio and receptor selectivity of the compounds tested on induction of cell proliferation. ERα agonists activate cell proliferation whereas ERβ suppresses ERα mediated cell proliferation. The responses in the MARCoNI assay reveal that upon ERα or ERβ activation by a specific agonist, the modulation of the interaction of the ERs with coregulators is very similar indicating only a limited number of differences upon ERα or ERβ activation by a specific ligand. Differences in the modulation of the interaction of the ERs with coregulators between the different agonists were more pronounced. Based on ligand dependent differences in the modulation of the interaction of the ERs with coregulators, the MARCoNI assay was shown to be able to classify the ER agonists discriminating between different agonists for the same receptor, a characteristic not defined by the ER selective reporter gene or proliferation assays. It is concluded that the ultimate effect of the model compounds on proliferation of estrogen responsive cells depends on the intrinsic relative potency of the agonist towards ERα and ERβ and the cellular ERα/ERβ ratio whereas differences in the modulation of the interaction of the ERα and ERβ with coregulators contribute to the ligand dependent responses induced by estrogenic compounds.
本研究的目的是调查雌激素化合物诱导的配体反应中,雌激素受体α(ERα)和雌激素受体β(ERβ)与共调节因子相互作用的调节情况。为此,在ER选择性报告基因检测中,通过半数有效浓度(EC50)反映的内在相对效力以及对ERα和ERβ介导反应的最大效能,对选择性ERα和ERβ激动剂进行了表征,随后在具有可变ERα/ERβ比例的T47D-ERβ细胞中测试其对细胞增殖的诱导作用,最后使用MARCoNI检测法,利用来自66种不同共调节因子的154种独特的核受体共调节因子肽,测试ERα和ERβ与共调节因子相互作用的配体依赖性调节。所得结果揭示了所测试化合物的ERα/ERβ比例和受体选择性对细胞增殖诱导的重要影响。ERα激动剂激活细胞增殖,而ERβ抑制ERα介导的细胞增殖。MARCoNI检测中的反应表明,在特定激动剂激活ERα或ERβ后,ER与共调节因子相互作用的调节非常相似,这表明在特定配体激活ERα或ERβ后,差异有限。不同激动剂之间,ER与共调节因子相互作用调节的差异更为明显。基于ER与共调节因子相互作用调节的配体依赖性差异,MARCoNI检测法能够区分同一受体的不同激动剂,这是ER选择性报告基因或增殖检测所不具备的特性。得出的结论是,模型化合物对雌激素反应性细胞增殖的最终影响取决于激动剂对ERα和ERβ的内在相对效力以及细胞内的ERα/ERβ比例,而ERα和ERβ与共调节因子相互作用调节的差异有助于雌激素化合物诱导的配体依赖性反应。